Skip to main content
    C

    Clearmind Medicine Inc. Common Shares (CMND)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.00
    -0.53 (-11.70%)

    Market Cap: $2.30M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Clearmind Medicine Inc. Common Shares (CMND) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Clearmind Medicine Inc. Common Shares are CNS Pharmaceuticals (CNSP), Creative Medical Technology Holdings (CELZ) and Purple Biotech (PPBT). By market cap, Clearmind Medicine Inc. Common Shares ranks 10th of the 13 companies on this page; Reviva Pharmaceuticals Holdings (RVPH) is the largest at $4.63M.

    Peer Comparison

    CMND's ROIC of -56.8% is above the peer median of -123.2%, and its revenue growth of 0.0% is in line with the median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Clearmind Medicine Inc. Common Shares (CMND)$2.30MN/AN/A0.0%-56.8%0.0%0.00%
    CNS Pharmaceuticals Inc (CNSP)$4.22MN/AN/A0.0%N/A0.0%0.00%
    Creative Medical Technology Holdings Inc (CELZ)$4.01MN/AN/A0.0%N/A0.0%0.00%
    Purple Biotech (PPBT)$2.65MN/AN/A0.0%-156.2%0.0%0.00%
    Curis Inc (CRIS)$2.97MN/A1.6x0.0%N/A-66.0%0.00%
    Liminatus Pharma, Inc. Class A Common Stock (LIMN)$4.02MN/AN/A0.0%-247.2%0.0%0.00%
    NuCana PLC (NCNA)$3.88MN/AN/A0.0%N/A0.0%0.00%
    Kairos Pharma, Ltd. (KAPA)$1.54MN/AN/A0.0%N/A0.0%0.00%
    Enlivex Therapeutics Ltd (ENLV)$1.82MN/AN/A0.0%-0.3%0.0%0.00%
    Revelation Biosciences Inc (REVB)$2.43MN/AN/A0.0%N/A0.0%0.00%
    BioRestorative Therapies Inc (BRTX)$2.06MN/A70.3x0.0%-289.9%-7.3%0.00%
    Reviva Pharmaceuticals Holdings Inc. (RVPH)$4.63MN/AN/A0.0%-90.2%0.0%0.00%
    Jupiter Neurosciences, Inc. Common Stock (JUNS)$2.32MN/A21.0x0.0%1154.5%0.0%0.00%
    Peer median$2.81MN/A21.0x0.0%-123.2%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Clearmind Medicine Inc. Common Shares, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    CNS Pharmaceuticals Inc (CNSP)
    CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, is dedicated to the development of cancer drug candidates for the treatment of brain and central...
    CNSP competitors
    Creative Medical Technology Holdings Inc (CELZ)
    Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics...
    CELZ competitors
    Purple Biotech (PPBT)
    Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs in the United...
    PPBT competitors
    Curis Inc (CRIS)
    Curis, Inc., a biotechnology company, is dedicated to the discovery and development of drug candidates for the treatment of human cancers in the United States.
    CRIS competitors
    Liminatus Pharma, Inc. Class A Common Stock (LIMN)
    Liminatus Pharma, Inc. is a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is headquartered in LA Palma, California.
    LIMN competitors
    NuCana PLC (NCNA)
    NuCana plc, a clinical-stage biopharmaceutical company, is dedicated to the development of products for the treatment of cancer.
    NCNA competitors
    Kairos Pharma, Ltd. (KAPA)
    Kairos Pharma, Ltd. is a clinical-stage biopharmaceutical company that develops therapeutics for cancer patients.
    KAPA competitors
    Enlivex Therapeutics Ltd (ENLV)
    Enlivex Therapeutics Ltd. is a clinical stage immunotherapy company. The company is headquartered in Nes Ziona, Israel.
    ENLV competitors
    Revelation Biosciences Inc (REVB)
    Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of immunological diagnostics and therapeutics...
    REVB competitors
    BioRestorative Therapies Inc (BRTX)
    BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue...
    BRTX competitors
    Reviva Pharmaceuticals Holdings Inc. (RVPH)
    Reviva Pharmaceuticals Holdings Inc. (RVPH) is a clinical-stage biopharmaceutical company dedicated to developing groundbreaking therapies for central nervous...
    RVPH competitors
    Jupiter Neurosciences, Inc. Common Stock (JUNS)
    Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company...
    JUNS competitors

    Frequently Asked Questions About CMND

    Who are Clearmind Medicine Inc. Common Shares' main competitors?

    The companies most similar to Clearmind Medicine Inc. Common Shares include CNS Pharmaceuticals (CNSP), Creative Medical Technology Holdings (CELZ), Purple Biotech (PPBT), Curis (CRIS) and Liminatus Pharma, Inc. Class A Common Stock (LIMN), listed from the closest match.

    Who is Clearmind Medicine Inc. Common Shares' biggest competitor?

    Reviva Pharmaceuticals Holdings (RVPH) is the largest of the similar companies at $4.63M; CNS Pharmaceuticals (CNSP) is the closest match by business profile, size, sector and industry.

    How does CMND stock compare with its competitors?

    CMND's net margin is 0.0% against a peer median of 0.0%.

    Which of Clearmind Medicine Inc. Common Shares' competitors pays a higher dividend?

    Clearmind Medicine Inc. Common Shares pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Clearmind Medicine Inc. Common Shares bigger than its competitors?

    No. Clearmind Medicine Inc. Common Shares is 10th by market cap among the 13 companies on this page; the largest is Reviva Pharmaceuticals Holdings (RVPH) at $4.63M.